Quick Answer
USANA HEALTH SCIENCES INC reported Gross Profit of $724.41 million for the year ending 2025.
- USANA HEALTH SCIENCES INC showed an increase of +4.5% in Gross Profit from 2024 to 2025.
- This data is from USANA HEALTH SCIENCES INC's annual report (Form 10-K), filed with the SEC on March 16, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2013: $142.20 million | Q4 2013: $152.49 million | Q1 2014: $148.57 million | Q2 2014: $153.39 million | Q3 2014: $157.36 million | Q4 2014: $190.35 million | Q1 2015: $181.01 million | Q2 2015: $193.16 million | Q3 2015: $192.24 million | Q4 2015: $192.40 million | Q1 2016: $197.53 million | Q2 2016: $212.54 million | Q3 2016: $209.24 million | Q4 2016: $206.58 million | Q1 2017: $212.67 million | Q2 2017: $213.16 million | Q3 2017: $214.63 million | Q4 2017: $227.40 million | Q1 2018: $242.62 million | Q2 2018: $251.47 million | Q3 2018: $244.89 million | Q4 2018: $249.56 million | Q1 2019: $227.09 million | Q2 2019: $209.52 million | Q3 2019: $212.78 million | Q4 2019: $224.01 million | Q1 2020: $220.56 million | Q2 2020: $211.32 million | Q3 2020: $242.16 million | Q1 2021: $250.33 million | Q2 2021: $279.82 million | Q3 2021: $223.64 million | Q1 2022: $221.48 million | Q2 2022: $214.96 million | Q3 2022: $186.74 million | Q1 2023: $199.84 million | Q2 2023: $194.88 million | Q3 2023: $170.84 million | Q1 2024: $184.73 million | Q2 2024: $172.54 million | Q3 2024: $160.96 million | Q1 2025: $197.09 million | Q2 2025: $185.66 million | Q3 2025: $164.86 million.
- Over the full 17 years of available data (2009 to 2025), USANA HEALTH SCIENCES INC's Gross Profit has grown by 108.7%.
- Historical annual values: Fiscal year 2025: $724.41 million | Fiscal year 2024: $693.29 million | Fiscal year 2023: $744.32 million | Fiscal year 2022: $804.71 million | Fiscal year 2021: $968.57 million | Fiscal year 2020: $925.53 million | Fiscal year 2019: $873.40 million | Fiscal year 2018: $988.54 million | Fiscal year 2017: $867.86 million | Fiscal year 2016: $825.89 million | Fiscal year 2015: $758.82 million | Fiscal year 2014: $649.68 million | Fiscal year 2013: $590.74 million | Fiscal year 2012: $532.92 million | Fiscal year 2011: $480.25 million | Fiscal year 2010: $422.16 million | Fiscal year 2009: $347.14 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: